Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1990-06-11
1991-10-22
Shah, Mukund J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546110, C07D22110, A61K 31435
Patent
active
050596071
ABSTRACT:
A benzisoquinoline derivative of the formula: ##STR1## wherein R.sup.1 is hydrogen, C1-4 alkyl, C1-4 alkoxy, hydroxy or halogen;
REFERENCES:
Covey, Chemical Abstacts vol. 59, No. 3899b (1963).
North et al., Chemical Abstracts vol. 112, No. 198377a (1989).
Wolfbeis et al., Chemical Abstracts, vol. 95, No. 8, Aug. 24, 1981., abstract No. 63658c.
Carberas et al., Chemical Abstracts, vol. 108, No. 3, Jan. 18, 1988, abstract No. 21750h.
Nonomiya et al., Chemical Abstracts, vol. 86, No. 7, Feb. 14, 1977, abstract No. 43531s.
Kawamura Masonari
Okegawa Tadao
Ono-Pharmaceutical Co., Ltd.
Patton Philip
Shah Mukund J.
LandOfFree
Imidazolyl benzisoquinolines useful as 5-HT.sub.3 receptor antag does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Imidazolyl benzisoquinolines useful as 5-HT.sub.3 receptor antag, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Imidazolyl benzisoquinolines useful as 5-HT.sub.3 receptor antag will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-108720